Skip to content

Neuro-Kinesis

2 viewers · 30d

Total raised

$51K

+$51K this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $51K
ROUNDS
1
INVESTORS
5
FOUNDED
N/A
HQ
Inglewood, CA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Neuro-Kinesis Corporation develops smart surgical tools built around its patented biosensor technology, which converts analog biological signals at the tissue interface into digital data a microprocessor can analyze. Its lead device is the Huygens catheter, a diagnostic catheter that delivers real-time biometric feedback with higher signal resolution for cardiac electrophysiology. The company is also developing the SMARTBrain retractor for neurosurgery and holds the CGCI robotic catheter navigation system, which uses magnetic field energy and real-time 3D mapping and has been CE-marked for sale in Europe. It is based in Inglewood, California and was incorporated in 2022.

What sets it apart

Roughly 15 years of patented biosensor development applied at the tip of the instrument, so surgeons get real-time digital readouts of tissue state during a procedure instead of inferring it from lower-resolution downstream signals.

Funding history

1 round
EquityApr 13, 2026 · $10K min
Form D
+$51K$51K total

Latest SEC filings

via EDGAR · CIK 0001814194
Form D · Apr 13, 2026View on EDGAR

Products

1 tracked

Huygens Catheter

Interventional cardiology / electrophysiology device

A diagnostic catheter carrying the company's biosensor, delivering intelligent real-time biometric feedback with enhanced signal resolution and sensor-point data processing during cardiac procedures. Phase one development is complete and animal studies are underway toward clinical validation.

  • Patented biosensor at the catheter tip
  • Real-time biometric feedback during the procedure
  • Enhanced signal resolution over conventional mapping catheters
  • Sensor-point data processing into digital, analyzable output

Links

WebsiteSEC EDGAR filings